Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- DKK | -.--% | -.--% | -0,50 % |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 01.03.16 |
Chief Tech/Sci/R&D Officer | - | 13.09.17 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
Josep Grinyo
PRN | Corporate Officer/Principal | - | - |
Noel Barnard
LAW | General Counsel | - | 01.03.16 |
Mark Hensley
PRN | Corporate Officer/Principal | - | 01.04.16 |
Rita L. Mannella
HRO | Human Resources Officer | - | 01.01.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 739 741 590 | 173 932 405 ( 9,998 %) | 0 | 9,998 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The private company is based in Edison, NJ. |
Pharmaceuticals: Major
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-0,50 % | 1,64 Mrd. | |
+12,05 % | 9,18 Mrd. | |
-16,33 % | 4,78 Mrd. | |
+6,40 % | 3,87 Mrd. | |
+26,98 % | 3,73 Mrd. | |
+26,92 % | 2,52 Mrd. | |
-26,55 % | 2,27 Mrd. | |
-25,02 % | 2,21 Mrd. | |
+5,82 % | 1,95 Mrd. | |
+3,85 % | 1,63 Mrd. |
- Börse
- Aktien
- A0LEJ1 Aktie
- Unternehmen Veloxis Pharmaceuticals A/S